Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity of Pandemic Influenza A (H1N1)Vaccine”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Large-scale testing (Phase 3)Study completedNCT01053143
What this trial is testing

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Who this might be right for
InfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Testing effectiveness (Phase 2)Study completedNCT00992212
What this trial is testing

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

Who this might be right for
Pandemic Influenza Disease
Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT00971425
What this trial is testing

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Who this might be right for
Influenza
GlaxoSmithKline 145
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Testing effectiveness (Phase 2)Study completedNCT00976469
What this trial is testing

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT00959465
What this trial is testing

A/H1N1 Immunogenicity and Safety in Adults

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 408
Testing effectiveness (Phase 2)Study completedNCT00953524
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 849
Testing effectiveness (Phase 2)Study completedNCT00952276
What this trial is testing

Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi 548
Testing effectiveness (Phase 2)Study completedNCT01666262
What this trial is testing

Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais

Who this might be right for
Healthy
Mahidol University 363
Early research (Phase 1)Study completedNCT01111968
What this trial is testing

Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines

Who this might be right for
Influenza
Butantan Institute 266
Testing effectiveness (Phase 2)Study completedNCT01161160
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 209
Large-scale testing (Phase 3)Study completedNCT00971542
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 778
Testing effectiveness (Phase 2)Study completedNCT00954798
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 450
Not applicableStudy completedNCT01218685
What this trial is testing

Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants

Who this might be right for
Immunocompromised PatientsSafety of Pandemic Influenza A (H1N1)VaccineImmunogenicity of Pandemic Influenza A (H1N1)Vaccine
Butantan Institute 1,152
Testing effectiveness (Phase 2)Study completedNCT00952419
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 474
Testing effectiveness (Phase 2)Study completedNCT01089660
What this trial is testing

The Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 202
Testing effectiveness (Phase 2)Study completedNCT01494740
What this trial is testing

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

Who this might be right for
Influenza
Shanghai Institute Of Biological Products 312
Post-approval studies (Phase 4)Study completedNCT02143882
What this trial is testing

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).

Who this might be right for
Live Attenuated Influenza Vaccine
Public Health England 300
Next Page